Reply to Ganda and colleagues’ letter to the editor regarding “Defining the Key Clinician Skills and Attributes For Competency in Managing Patients with Osteoporosis and Fragility Fractures” by LE Jackson and colleagues

2024-9-17

Eiken syndrome with parathyroid hormone resistance due to a novel parathyroid hormone receptor type 1 mutation: clinical features and functional analysis

2024-9-14

Trial emulation to improve fracture prevention treatment in men: editorial on ASBMR-24030174

2024-9-11

Independent contribution of gonads and sex chromosomes to sex differences in bone mass and strength in the four-Core genotypes mouse model

2024-9-10

Defining the key clinician skills and attributes for competency managing patients with osteoporosis and fragility fractures

2024-9-10

Short-term risk of fracture is increased by deficits in cortical and trabecular bone microarchitecture independent of DXA BMD and FRAX: bone microarchitecture international consortium (BoMIC) prospective cohorts

2024-9-5

The G protein-coupled receptor ADGRG6 maintains mouse growth plate homeostasis through IHH Signaling

2024-9-5

Weight change, variability, and trajectories and risk of hip fracture among older adults with Dysglycemia: the cardiovascular health study

2024-9-4

Longitudinal Changes in Bone Mineral Density in Adults with Cystic Fibrosis

2024-9-2

Characterization of flare-ups and impact of Garetosmab in adults with Fibrodysplasia Ossificans Progressiva: a post hoc analysis of the randomized, double-blind, placebo-controlled LUMINA-1 trial

2024-8-31

An improved understanding of paediatric chronic nonbacterial osteomyelitis (CNO) pathophysiology informs current and future treatment

2024-8-29

Prevalence of HIV-associated osteoporosis and fracture risk in mid-life women: a cross-sectional study in Zimbabwe

2024-8-24

Isolation and characterization of bone mesenchymal cell small extracellular vesicles using a novel mouse model

2024-8-22

Genomic structural variations link multiple genes to bone mineral density in a multi-ethnic cohort study: Louisiana osteoporosis study

2024-8-21

Causal inference in health and disease: a review of the principles and applications of Mendelian randomization

2024-8-21

Development and reporting of artificial intelligence in osteoporosis management

2024-8-20

Microvascular Disease and Early Diabetes Onset Are Associated with Deficits in Femoral Neck Bone Density and Structure Among Older Adults with Longstanding Type 1 Diabetes

2024-8-16

Male–Female Spatio-Temporal Differences of Age-Related Bone Changes Show Faster Bone Deterioration in Older Women at Femoral Regions Associated with Incident Hip Fracture

2024-8-16

Nephrocalcinosis and Kidney Function in Children and Adults with X-linked Hypophosphatemia: Baseline Results from a Large Longitudinal Study

2024-8-16

Fractures by race and ethnicity in a diverse sample of postmenopausal women: a current evaluation among Hispanic and Asian origin groups

2024-8-15

Safety, Pharmacokinetics, and Pharmacodynamics of Efzimfotase Alfa, a Second-generation Enzyme Replacement Therapy: Phase 1, Dose-escalation Study in Adults with Hypophosphatasia

2024-8-13

One-carbon metabolism supports s-adenosylmethionine and m6A methylation to control the osteogenesis of BMSCs and bone formation

2024-8-10

Gene-based association analysis of a large patient cohort provides insights into genetics of atypical femur fractures

2024-8-10

Response to the letter to the editor regarding “The American Society for Bone and Mineral Research Task Force on clinical algorithms for fracture risk report”

2024-8-10

Multi-omics analyses reveal aberrant differentiation trajectory with WNT1 loss-of-function in type XV osteogenesis imperfecta

2024-8-9

The relationship between treatment-related changes in total hip bone mineral density measured after 12, 18 and 24 months and fracture risk reduction in osteoporosis clinical trials: the FNIH-ASBMR-SABRE Project

2024-8-4

SNX10 regulates osteoclastogenic cell fusion and osteoclast size in mice

2024-8-2

Loss of the long form of <i>Plod2</i> phenocopies contractures of Bruck syndrome—osteogenesis imperfecta

2024-8-1

Skeletal effects of adjuvant zoledronic acid and its cessation in women with early-stage breast cancer

2024-7-30

Goal-Directed Osteoporosis Treatment: ASBMR/BHOF Task Force Position Statement 2024

2024-7-29

Are osteoblasts multiple cell types? A new diversity in skeletal stem cells and their derivatives

2024-7-25

Structural and Molecular Imaging-based Characterization of Soft Tissue and Vascular Calcification in Hyperphosphatemic Familial Tumoral Calcinosis

2024-7-24

Romosozumab Followed by Denosumab Versus Denosumab Only: A Post Hoc Analysis of FRAME and FRAME Extension

2024-7-23

Letter to the editor regarding “The American Society for Bone and Mineral Research Task Force on clinical algorithms for fracture risk report”

2024-7-22

Impact of the SIK3 Pathway Inhibition on Osteoclast Differentiation via Oxidative Phosphorylation

2024-7-20

Evaluation of Romosozumab’s Effects on Bone Marrow Adiposity in Postmenopausal Osteoporotic Women: Results from the FRAME Bone Biopsy Sub-Study

2024-7-18

Setrusumab for the Treatment of Osteogenesis Imperfecta: 12-Month Results from the Phase 2b Asteroid Study

2024-7-16

Calorie Restriction in Mice Impairs Cortical but not Trabecular Peak Bone Mass by Suppressing Bone Remodeling

2024-7-12

High physical activity is associated with greater cortical bone size, better physical function, and with lower risk of incident fractures independently of clinical risk factors in older women from the SUPERB study

2024-7-12

Hypophosphatemic Rickets and Short Stature

2024-7-11

Femoral neck width and hip fracture risk

2024-7-11

Osteoclast-derived coupling factors: origins and state-of-play Louis V Avioli Lecture, ASBMR 2023

2024-7-11

Following hip fracture, hospital organisational factors associated with prescription of anti-osteoporosis medication on discharge, to address imminent refracture risk: a record-linkage study

2024-7-11

Bone matrix properties in adults with osteogenesis imperfecta are not adversely affected by Setrusumab - a sclerostin neutralizing antibody

2024-7-10

The comparative effect of teriparatide and denosumab on activins, follistatins and inhibins in women with postmenopausal osteoporosis

2024-7-8

Direct activation of PI3K in osteoblasts and osteocytes strengthens murine bone through sex-specific actions on cortical surfaces

2024-7-3

Zoledronic acid for hip fracture during initial hospitalization

2024-7-2

Improving the value and interpretation of observational studies comparing treatment effects of osteoporosis medications depends on standardized reporting of methods

2024-7-1

The Multifaceted Roles of Mitochondria in Osteoblasts: from Energy Production to Mitochondrial-Derived Vesicle Secretion

2024-7-1

Response to the editor of JBMR regarding the letter related to “Opportunistic screening with CT: comparison of phantomless BMD calibration methods”

2024-6-27